Awards and Rankings March 15, 2021

Goodwin Named the Number One Firm for Venture Capital and Private Equity Rounds and Pharma, Medical and Biotech M&A in 2020

For the third consecutive year, Refinitiv has named Goodwin the number one global advisor for Venture Capital and Private Equity Rounds and Venture Capital Rounds in its 2020 Global Venture Capital and Private Equity Legal Advisory League TablesGoodwin led all law firms by advising firms and companies in 439 total rounds, nearly 60% more rounds than its next closest competitor.

 

Building upon this success, Mergermarket’s Deal Drivers Americas FY 20 Report has named Goodwin the number one firm (by Deal Count) for Pharma, Medical & Biotech M&A in North America, while Mergermarket’s Deal Drivers EMEA FY 20 Report recognized Goodwin as the number two firm (by Value) for Pharma, Medical & Biotech M&A in Europe, the Middle East and Africa. Goodwin was the only firm to finish at the top of both categories.

 

Additionally, Pitchbook’s Global League Tables FY 20 demonstrated significant growth by the firm over the past year across a number of categories. This includes a substantial rankings increase in Venture Capital – Most Active in Europe (by Deal Count), Private Equity – Most Active in Exits (by Deal Count), and M&A – Most Active in United States (by Deal Count).

 

These results further reinforce the breadth and resiliency of Goodwin’s capital-meets-innovation platform. From the firm’s collaborative team of venture capital and private equity lawyers to its more than 100 corporate M&A lawyers, Goodwin continues to help innovators and investors around the world transform the technology, healthcare and life sciences sectors.

 

Goodwin’s standout 2020 league tables results include:

 

Refinitiv Global Legal Advisory League Tables

  • #1 Advisor to Firm: All Rounds (by Deal Count)
  • #1 Advisor to Firm: Venture Capital Rounds (by Deal Count)
  • #2 Advisor to Company: All Rounds (by Deal Count)
  • #2 Advisor to Company: Venture Capital Rounds (by Deal Count)

Mergermarket Deal Drivers FY 20

  • #1 Pharma, Medical & Biotech M&A in North America (by Deal Count)
  • #2 Pharma, Medical & Biotech M&A in EMEA (by Deal Value)
  • #3 Tech, Media, and Telecoms M&A in North America (by Deal Count)

Pitchbook Global League Tables FY 20

  • #2 Venture Capital – Most Active in Europe (by Deal Count)
  • #2 Venture Capital – Most Active in Exits (by Deal Count)
  • #3 Venture Capital – Most Active in Early Stage (by Deal Count)
  • #3 Venture Capital – Most Active in Pharma & Biotech (by Deal Count)
  • #3 Private Equity – Company Representation in United States (by Deal Count)
  • #3 M&A – Most Active in United States (by Deal Count)
  • #4 Venture Capital – Most Active in Healthcare Devices & Supplies (by Deal Count)
  • #4 Venture Capital – Most Active in Healthcare Services & Systems (by Deal Count)
  • #4 Private Equity – Healthcare (by Deal Count)